Search Results 731-740 of 16836 for Linaclotide

  1. Neurology - Clinical trials

    Rochester, Minn. The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body ...

  2. Clinical trials - Oncology (Medical)

    Rochester, Minn. The purpose of this study is to assess tumor cells from blood and bone marrow from patients with myeloid neoplasms for epigenetic dysregulation ...

  4. A Study to Evaluate the Safety and Effectiveness of DCR-PHXC to Treat Patients with Primary Hyperoxaluria Type 1 or 2 and Severe Renal Impairment - Mayo Clinic

    The purpose of this study is to evaluate DCR-PHXC in patients with primary hyperoxaluria type 1 (PH1) and severe renal impairment, with or without dialysis.

  5. Clinical trials - Oncology (Medical)

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  6. Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD Patients - Mayo Clinic

    Since left ventricular assist device (LVAD) can not reverse remodeling of the heart whereas it can improve hemodynamics, CD-NP may be novel anti-fibrotic and ...

  7. Neurology - Clinical trials

    The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and ...

  8. Clinical trials - Oncology (Medical)

    The purpose of this study is to to bring molecular risk prediction for breast cancer into the clinical arena through: the establishment of a large tissue ...

  9. Clinical trials - Oncology (Medical)

    For example, inflammatory bowel disease is a major predisposing factor for colorectal cancer occurrence, implicating inflammation in the development of ...

  10. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

    This is a combination Phase I and Phase II study, with an aim to evaluate the combination of GSK525762 and fulvestrant in women with advanced or metastatic ER+ ...